Thanks, Kim, and good morning, everyone. Two brief reminders before I begin. First, I'll be discussing our results on a continuing operations basis, which excludes Batesville. And second, I will be making organic comparisons that exclude the impacts of acquisitions, divestitures, and foreign currency exchange. Now turning to our consolidated performance on Slide 6. We delivered revenue of $691 million, an increase of 22% compared to the prior year, primarily due to acquisitions and higher aftermarket parts and service revenue. On an organic basis, revenue increased 9% year-over-year led by 11% organic growth within our APS segment. Adjusted EBITDA of $109 million increased 8% or 3% organically as favorable pricing and productivity improvements were partially offset by cost inflation. Adjusted EBITDA margin of 15.7% decreased 200 basis points, primarily due to unfavorable product mix and the dilutive effect of the acquisitions. As we previously discussed, the recent acquisitions currently operate with lower relative margins. However, we do expect to bring these margins in line with historical APS margins over the next few years, as we drive synergies and productivity through the deployment of the Hillenbrand operating model. We reported GAAP net income from continuing operations of $24 million or $0.33 per share. Adjusted earnings per share of $0.74 increased $0.09, or 14% compared to the prior year, primarily due to pricing and productivity improvements, higher EPS volume, the impact of acquisitions, and fewer shares outstanding. This is partially offset by inflation, unfavorable foreign currency exchange and higher interest expense. The adjusted effective tax rate in the quarter was 33.5%. We anticipate our full year tax rate to be approximately 31%, which is at the high-end of our previously provided range, primarily due to unfavorable geographic mix. We generated cash flow from operations of $50 million in the quarter, up approximately $65 million from the prior year, primarily due to favorable timing of working capital. Capital expenditures were $17 million in the quarter, and we returned approximately $15 million to shareholders through our quarterly dividend. As the supply chain environment normalizes, we continue to expect improvements in our working capital profile, particularly through lower inventory and through the reduction of unbilled receivables related to large projects. We also anticipate that higher order volume will generate an increase in customer advances in the back half of the year, leading to stronger cash flow in the second half compared to the first half. We maintain our expectation that full year cash conversion will be in a range of 80% to 85% for fiscal 2023, while our longer term target remains at approximately 100%. Now moving to segment performance, starting with APS on Slide 7. APS revenue of $431 million increased 37% compared to the prior year, driven by acquisitions, higher aftermarket parts and service revenue and favorable pricing. Organic revenue increased 11% year-over-year. Adjusted EBITDA of $73 million increased 12% year-over-year or 2% organically as favorable pricing, higher volume and productivity improvements were partially offset by cost inflation and growth investments. Adjusted EBITDA margin of 17% decreased 370 basis points, primarily due to the dilutive effect of the acquisitions, and an increase in growth investments. Margins for the acquisitions were a bit lower in the quarter than anticipated, primarily due to customer delays negatively impacting volume. As I mentioned earlier, we still expect to improve these margins towards historical segment levels over the next few years. Backlog of $1.67 billion, increased 30% compared to the prior year or 13% on an organic basis, primarily driven by increased orders for large plastics systems and record orders for aftermarket parts and service. As Kim mentioned, we are pleased with the robust pipelines in our key growth platforms of durable plastics, recycling and food, which we expect to translate into higher growth in the second half of the year. Turning to MTS on Slide 8. Revenue of $260 million, increased 4% year-over-year or 7% organically as an increase in injection molding equipment, favorable pricing and higher aftermarket parts and service was partially offset by a decrease in hot runner equipment, which we anticipated coming into the quarter. Adjusted EBITDA of $48 million, decreased 6% or 2% organically, and adjusted EBITDA margin of 18.2%, decreased 190 basis points, primarily due to the elevated relative volume of injection molding equipment, which, as we've discussed, comes at a lower relative margin when compared to hot runners. As Kim mentioned, we expect this mix to normalize in the second half of the year, which will result in overall improvement in margins for the segment. Backlog of $298 million decreased 29% compared to the prior year, primarily due to the execution of the existing backlog and lower orders for injection molding equipment. We delivered record revenue from our injection molding product line in the quarter, which is a testament to the team's relentless focus on execution. The order softness we saw throughout the quarter was in line with our expectations, and we are seeing pipelines improve across most applications and geographies. We expect to see orders continue to pick up as we work through the remainder of the second half of the fiscal year. Turning to the balance sheet on Slide 9. Net debt at the end of the quarter was just under $1 billion, and our net debt to pro forma adjusted EBITDA ratio was 2.2x. At quarter end, we had liquidity of approximately $1.1 billion, including $350 million in cash on hand and the remainder available under our revolving credit facility. I'd like to highlight that in June, we expect to make a tax payment related to the Batesville sale of approximately $150 million. Including this tax payment, our net leverage ratio will be approximately 2.5x as of the end of the second quarter, which is back within our targeted range of 1.7x to 2.7x. Turning to Slide 10. As many of you know, we have a strong track record of deleveraging following acquisitions, and we expect to continue this track record as we move forward, while maintaining the disciplined capital deployment strategy that is focused on profitable growth and shareholder value creation. As we've consistently communicated, our capital deployment framework is based around four key priorities: driving profitable growth through attractive organic and inorganic investment opportunities, returning cash to shareholders through our attractive dividend policy, and opportunistic share repurchases, and maintaining an appropriate leverage profile with a target net leverage of 1.7x to 2.7x. As we make progress integrating our recent acquisitions, we continue to evaluate potential strategic acquisitions that strengthen our capabilities in key end markets, accelerate our profitable growth strategy and those that will provide a strong return to shareholders over the long term. Now moving to Slide 12. As we enter the second half of the fiscal year, we are updating our guidance based on performance in the first half as well as what we see in current demand and operating environment. Our guidance now assumes slightly increased expected revenue of approximately $2.81 billion to $2.86 billion for the year, previously $2.77 billion to $2.86 billion. We are maintaining the midpoint of our adjusted EPS range while narrowing slightly to $3.30 to $3.50 per share from a previous range of $3.25 to $3.55 per share. Now turning to the segments. For APS, we are refining our expected annual revenue range to be $1.8 billion to $1.83 billion, previously $1.79 billion to $1.84 billion. Our assumption for underlying organic growth remains strong at approximately 10% to 12%. We are lowering our expectations for adjusted EBITDA margin to be in the range of 18.5% to 19%, previously 19% to 20%, primarily due to unfavorable product mix and the dilutive effect of price cost that has remained more elevated than anticipated. This guidance reflects underlying organic margin expansion of 40 basis points to 90 basis points. For MTS, we are slightly raising our expected annual revenue range to be $1.01 billion to $1.03 billion, previously $980 million to $1.02 billion. We are maintaining our previous guidance for EBITDA margin in the range of 19% to 20% based on the expected product mix in the second half of the year. With the ongoing macro uncertainty, we are providing a Q3 guidance range for adjusted EPS, which we expect to be $0.88 to $0.94, which reflects year-over-year growth on a continuing operations basis of 28% to 36% and strong sequential improvements in both segments. Please review Slide 12 for additional guidance assumptions. With that, I'll turn the call back over to Kim.